Cyclic GMP and nitroprusside inhibit the activation of human platelets by fluoroaluminate
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1014 (2) , 203-206
- https://doi.org/10.1016/0167-4889(89)90035-9
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxideBritish Journal of Pharmacology, 1987
- Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in plateletsBritish Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Endothelium‐derived relaxing factor inhibits in vitro platelet aggregationBritish Journal of Pharmacology, 1987
- Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human plateletsBiochemical and Biophysical Research Communications, 1986
- Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase CFEBS Letters, 1985
- The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function.Circulation, 1982
- Inhibitory action of guanosine 3′,5′-monophosphate on thrombin-induced phosphatidylinositol turnover and protein phosphorylation in human plateletsBiochemical and Biophysical Research Communications, 1981
- Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilatorsBlood, 1981